Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus in autosomal dominant polycystic kidney disease
2006-003427-37Phase 2Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of sirolimus in autosomal dominant polycystic kidney disease (ADPKD) (2 arms), sponsored by Mario Negri Institute for Pharmacological Research. Primary endpoint: Change from baseline in total kidney volume. Started Dec 2006; status: completed.
02
Drugs
sirolimus
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on 2006-003427-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003427-37.